The role of JAK/STAT signaling in AML LSCs growth and survival was investigated several years later by evaluating the expression levels of JAK and STAT in AML patient samples at diagnosis and relapse[94]. This evidence concerns the gene SOAT1 and acute myeloid leukemia.